control | PD | PD (disease duration ≤ 3 years) | MSA-P | PSP | p value | |
---|---|---|---|---|---|---|
n | 29 | 94 | 36 | 15 | 7 | N/A |
Age1 (years) | 66.1 ± 8.8 | 68.6 ± 9.7 | 70.1 ± 8.6 | 67.3 ± 9.2 | 70.6 ± 9.9 | ns |
Males/females | 9/20 | 47/47 | 19/16 | 9/6 | 4/3 | N/A |
Disease duration2 (years) | N/A | 5.1 ± 4.4 | 1.5 ± 1.1 | 2.1 ± 1.7 | 2.4 ± 2.0 | ns |
HY stage2 | N/A | 2.3 ± 0.8 | 2.1 ± 0.7 | 3.0 ± 0.9* | 3.1 ± 0.8* | 0.0003 |
MMSE1 | 29.6 ± 0.7 | 28.4 ± 1.9 | 28.6 ± 1.5 | 28.5 ± 1.9 | 28.6 ± 1.5 | ns |
UPDRS (total)2 | N/A | 36.9 ± 17.2 | 34.7 ± 16.4 | 34.8 ± 15.6 | 48.2 ± 18.1 | ns |
UPDRS (part III)2 | N/A | 23.1 ± 11.5 | 22.4 ± 11.3 | 22.8 ± 13.1 | 26.2 ± 9.8 | ns |